Business Context and Reporting Period
This Form 8-K Current Report from First Advantage Corporation covers events occurring on June 15, 2022, and June 17, 2022. The filing primarily addresses corporate governance matters, including the results of the 2022 Annual Meeting of Stockholders and the subsequent appointment of a new director to the Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on governance and voting results rather than financial performance data.
Material Changes and Governance Actions
- Annual Meeting Results: On June 15, 2022, approximately 95% of entitled shares (145,496,253 shares) were present or represented by proxy.
- Director Elections: Stockholders elected Scott Staples and Susan R. Bell as Class I directors for a three-year term expiring in 2025. Both received over 123 million votes in favor.
- Accounting Firm Ratification: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The proposal received 145,257,697 votes for and 211,922 votes against.
- Board Expansion: On June 17, 2022, the Board increased its size from seven to eight members and elected Bridgett R. Price as a Class II director (term expiring in 2023).
- Committee Appointment: Dr. Price was appointed to the Audit Committee, replacing Ms. Bianca Stoica. The Board determined Dr. Price is independent and qualified for Audit Committee service.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. It notes that Dr. Price will receive customary non-employee director compensation and has entered into a standard indemnification agreement. No unusual items were reported.
Investor Verification Checklist
- Verify the voting percentages for the ratification of Deloitte & Touche LLP to assess shareholder sentiment on audit oversight.
- Review the "Non-Employee Director Compensation Policy" (referenced as Exhibit 10.8 in the 2021 10-K) to understand the specific compensation structure for Dr. Price.
- Confirm the independence status of the new Audit Committee member, Dr. Price, as disclosed in the filing.
- Check the definitive proxy statement dated April 28, 2022, for detailed biographies of the elected directors and further context on the proposals.